Cargando…

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma

PURPOSE: To evaluate the impact of postoperative radiotherapy (PORT) on patterns of failure and survivals in uterine carcinosarcoma patients treated with radical surgery. MATERIALS AND METHODS: Between October 1998 and August 2010, 19 patients with stage I-III uterine carcinosarcoma received curativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hae Jin, Kim, Hak Jae, Wu, Hong-Gyun, Kim, Hans, Ha, Sung Whan, Kang, Soon-Beom, Song, Yong-Sang, Park, Noh-Hyun, Kim, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429907/ https://www.ncbi.nlm.nih.gov/pubmed/22984675 http://dx.doi.org/10.3857/roj.2011.29.4.228

Ejemplares similares

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08)
por: Cha, Jihye, et al.
Publicado: (2016)

The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns
por: Yu, Jeong Il, et al.
Publicado: (2013)

Outcome analysis in patients with uterine sarcoma
por: Yu, Tosol, et al.
Publicado: (2015)

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
por: Cory, Lori, et al.
Publicado: (2022)

Carcinosarcoma in the Cecum
por: Ryu, Youngjoon, et al.
Publicado: (2012)

Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
por: Kim, Se Ik, et al.
Publicado: (2022)

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas
por: Gungorduk, Kemal, et al.
Publicado: (2015)

Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma
por: Yoon, Gun, et al.
Publicado: (2011)

Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study
por: Li, Yuan, et al.
Publicado: (2019)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
por: Gracia, Myriam, et al.
Publicado: (2023)

Adjuvant single-fraction radiotherapy is safe and effective for intractable keloids
por: Song, Changhoon, et al.
Publicado: (2014)

Carcinosarcoma of the uterine cervix arising from Müllerian ducts
por: Kim, Myounghwan, et al.
Publicado: (2015)

Survival outcomes after adjuvant radiotherapy for aggressive fibromatosis depend on time frame and nuclear β-catenin
por: Kim, Jae Sik, et al.
Publicado: (2019)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2020)

Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors
por: Yoon, Won Sup, et al.
Publicado: (2017)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
por: Iavazzo, C., et al.
Publicado: (2013)

Role of TGF-β signaling in uterine carcinosarcoma
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2015)

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

The prognostic significance of the heterologous component in uterine carcinosarcomas
por: Can, Behzat, et al.
Publicado: (2023)

Carcinosarcoma of the Maxillary Sinus
por: Moon, Jeong-Ki, et al.
Publicado: (2013)

Prognostic value of metabolic parameters determined by preoperative (18)F-FDG PET/CT in patients with uterine carcinosarcoma
por: Lee, Hyun Ju, et al.
Publicado: (2017)

The Role of Postoperative Radiotherapy for Carcinosarcoma of the Uterus
por: Vordermark, Dirk, et al.
Publicado: (2020)

Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study
por: Zwahlen, Daniel R., et al.
Publicado: (2016)

Primary carcinosarcoma of the gallbladder
por: Park, Sung Bae, et al.
Publicado: (2012)

A randomized prospective trial of the postoperative quality of life between laparoscopic uterine artery ligation and laparoscopy-assisted vaginal hysterectomy for the treatment of symptomatic uterine fibroids: clinical trial design
por: Kim, Hee Seung, et al.
Publicado: (2009)

Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy
por: Tan, Zhen, et al.
Publicado: (2017)

Brain Metastasis in a Young Patient with Uterine Carcinosarcoma
por: Katiyar, Vatsala, et al.
Publicado: (2019)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

Uterine Carcinosarcoma: A Case Report and Literature Review
por: Kord, Ali, et al.
Publicado: (2020)

The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
por: Moukarzel, Lea A., et al.
Publicado: (2021)

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
por: Imo, Chinonye S., et al.
Publicado: (2022)

Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
por: Nizam, Aaron, et al.
Publicado: (2019)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eohi91as4oiohf94gtg7gvndnh